Dr Emily Camm, Senior Research Scientist in the Neurodevelopment and Neuroprotection Research Group at Hudson Institute of Medical Research

Dr Emily Camm

Following completion of a BSc with Honours and a PhD in Fetal Physiology at Monash University, Dr Emily Camm undertook post-doctoral training at The University of Geneva and the University of Cambridge. Between 2015-2029, Dr Camm was a lecturer in human reproduction and placental and fetal physiology in the Department of Physiology, Development and Neuroscience at the University of Cambridge. In January 2020, Dr Camm was recruited to the Neurodevelopment and Neuroprotection Group at The Ritchie Centre.

Dr Camm uses a combination of high-resolution respirometry, stereological and molecular biology techniques to advance understanding of the physiology of neurodevelopment from the gene to the systems level. Her long term goal is to identify how conditions during early life, such as placental insufficiency or obesity, can programme neurodevelopment and increase susceptibility to degenerative diseases later in life. Dr Camm has published widely on the mechanisms underlying alterations in brain morphology and behaviour in offspring following hypoxia or glucocorticoid exposure, and the use of therapeutic strategies to improve outcomes in offspring from complicated pregnancies. More recently, Dr Camm has been focussing on feto-placental growth and metabolism, in particular, the hormonal control of mitochondrial function in placental and fetal tissues, and the role of these early life developmental processes in programming adult health.

Previous funding: Medical Research Council (UK), The Royal Society (UK) and the University of Cambridge